GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » J.B. Chemicals & Pharmaceuticals Ltd (NSE:JBCHEPHARM) » Definitions » 10-Year ROIIC %

J.B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) 10-Year ROIIC % : 21.41% (As of Mar. 2024)


View and export this data going back to 2003. Start your Free Trial

What is J.B. Chemicals & Pharmaceuticals 10-Year ROIIC %?

10-Year Return on Invested Incremental Capital (10-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 10-year. J.B. Chemicals & Pharmaceuticals's 10-Year ROIIC % for the quarter that ended in Mar. 2024 was 21.41%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.

The industry rank for J.B. Chemicals & Pharmaceuticals's 10-Year ROIIC % or its related term are showing as below:

NSE:JBCHEPHARM's 10-Year ROIIC % is ranked better than
79.42% of 933 companies
in the Drug Manufacturers industry
Industry Median: 3.65 vs NSE:JBCHEPHARM: 21.41

J.B. Chemicals & Pharmaceuticals 10-Year ROIIC % Historical Data

The historical data trend for J.B. Chemicals & Pharmaceuticals's 10-Year ROIIC % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

J.B. Chemicals & Pharmaceuticals 10-Year ROIIC % Chart

J.B. Chemicals & Pharmaceuticals Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
10-Year ROIIC %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 23.89 39.60 19.75 17.74 21.41

J.B. Chemicals & Pharmaceuticals Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
10-Year ROIIC % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - 21.41 - -

Competitive Comparison of J.B. Chemicals & Pharmaceuticals's 10-Year ROIIC %

For the Drug Manufacturers - Specialty & Generic subindustry, J.B. Chemicals & Pharmaceuticals's 10-Year ROIIC %, along with its competitors' market caps and 10-Year ROIIC % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


J.B. Chemicals & Pharmaceuticals's 10-Year ROIIC % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, J.B. Chemicals & Pharmaceuticals's 10-Year ROIIC % distribution charts can be found below:

* The bar in red indicates where J.B. Chemicals & Pharmaceuticals's 10-Year ROIIC % falls into.



J.B. Chemicals & Pharmaceuticals 10-Year ROIIC % Calculation

J.B. Chemicals & Pharmaceuticals's 10-Year ROIIC % for the quarter that ended in Mar. 2024 is calculated as:

10-Year ROIIC %=10-Year Incremental Net Operating Profit After Taxes (NOPAT)**/10-Year Incremental Invested Capital**
=( 5534.87779 (Mar. 2024) - 622.9346123 (Mar. 2014) )/( 30781.651 (Mar. 2024) - 7844.509 (Mar. 2014) )
=4911.9431777/22937.142
=21.41%***

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** Annual data of NOPAT and Invested Capital was used to calculate 10-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.


J.B. Chemicals & Pharmaceuticals  (NSE:JBCHEPHARM) 10-Year ROIIC % Explanation

Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.

High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.

Be Aware

It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.


J.B. Chemicals & Pharmaceuticals 10-Year ROIIC % Related Terms

Thank you for viewing the detailed overview of J.B. Chemicals & Pharmaceuticals's 10-Year ROIIC % provided by GuruFocus.com. Please click on the following links to see related term pages.


J.B. Chemicals & Pharmaceuticals Business Description

Traded in Other Exchanges
Address
Appa Saheb Marathe Marg, Cnergy IT Park, Unit A2, 3rd floor, Unit A, 8th floor, Prabhadevi, Mumbai, MH, IND, 400 025
J.B. Chemicals & Pharmaceuticals Ltd is an India-based pharmaceutical company. It manufactures and markets pharmaceutical formulations, herbal remedies, and active pharmaceutical ingredients (APIs). The company's products include various pharmaceutical dosage forms like tablets, injectable, creams, ointments, lozenges, herbal liquids, and capsules. It also offers services including optimization of formulations, scale-up services, stability testing, regulatory support, packaging design, and commercial production. The group derives revenue from the manufacturing and marketing of a diverse range of pharmaceutical products. The company sells its products in India and also exports them to other international countries.

J.B. Chemicals & Pharmaceuticals Headlines

No Headlines